PMA P150013S003

Device
PD-L1 IHC 22C3 PHARMDX
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S003
Product code
PLS
Decision date
2016-12-01
Classification
Immunohistochemistry Assay, Antibody, Programmed Death-ligand 1
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Approval order statement
Approval for the DakoLink software version 4.1 update for the PD-L1 IHC 22C3 pharmDx.

Current openFDA PMA Record#

Device
PD-L1 IHC 22C3 PHARMDX
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S003
Product code
PLS
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision date
2016-12-01
Decision code
APPR
Date received
2016-08-19
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
Approval for the DakoLink software version 4.1 update for the PD-L1 IHC 22C3 pharmDx.